Invopharma provides fast-track market access to Rare Disease and specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA region)
Established in 2023, with a disruptive move to bring innovative treatment to MENA region as well as provide a high-quality first movers generics.
Invopharma is based in the Dubai Science Park (DSP), U.A.E. It also has an office in Ontario, Canada and supported with local distributors in GCC countries.
Operating through evidence-based medicine and the highest ethical standards, Invopharma provides its partners with fast and sustainable market access solutions into the MENA region. Invopharma employs highly qualified and experienced MSLs and KAMs. It offers regulatory, medical, PV and logistical support. Armed with knowledge of the local business culture and the vast network of trusted partners, Invopharma's expertise allows it to create market opportunities for innovative healthcare products and services.
Company Details
- Founded
- -
- Address
- Dubai, Ae
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.invopharma.com
- HQ
- Dubai
Invopharm Questions
Invopharm's website is http://www.invopharma.com
Invopharm's LinkedIn profile is https://ae.linkedin.com/company/invopharm
Invopharm's industry is
Pharmaceutical Manufacturing
Invopharm's top competitors are
Pharmax Pharmaceuticals Fz Llc,
Medspero Pharma Uae,
Annora Pharma Fz-Llc,
Skyepharma- Fully Integrated Cdmo,
Adcanpharma,
Gravity Pharma General Trading L.l.c,
Acorus Pharma Llc,
Trious Pharma,
Nutripharm,
Neobiocon.
Invopharm's categories are Pharmaceutical Manufacturing
Invopharm's founding year is 2023
